Search Database

Name

Belinostat

Alternate Names

Beleodaq
PXD 101
PXD-101
PXD101

Abbreviations

None

Category

Chemotherapy

Subcategory

Cytostatic agent--histone deacetylation inhibitor
HDAC inhibitor

NSC Number

726630

Primary Site

CLL
Multiple myeloma
NHL
advanced malignancies
others

Histology

None

Remarks

July 3, 2014 FDA granted accelerated approval to Belinostat for the treatment of patients with relapsed or refractory peripheral T-cell lymphoma (PTCL)

Coding

This drug should be coded
Glossary